Stockscreener 앱 받기
5.535
2.01%
0.065
Bausch Health Companies Inc 주식(BHC)의 최신 뉴스
Bausch Health Cos (BHC) Stock Price, News & Analysis $BHC - MarketBeat
Oligometastatic Disease Market Analysis Report 2026-2036, Profiles of Leading PlayersDompe Farmaceutici, Bausch Health, Merck, Pfizer, and Glenmark Pharmaceuticals - Yahoo Finance UK
BHC Stock Price, Quote & Chart | BAUSCH HEALTH COS INC (NYSE:BHC) - ChartMill
Bausch Health (NYSE: BHC) director sells 24,456 shares under plan - Stock Titan
New Bausch Health (BHC) director Eiry Roberts added as insider on Form 3 - Stock Titan
BHC: Sustained growth, China expansion, and BLCO monetization drive strategic priorities - TradingView
Bausch Health shareholders elect board members and approve auditor at annual meeting By Investing.com - Investing.com South Africa
Bausch Health shareholders elect board members and approve auditor at annual meeting - Investing.com
Shareholders of Bausch Health (NYSE: BHC) approve directors, pay and PwC - Stock Titan
Press Release: Bausch Health Announces 2026 Annual Meeting of Shareholder Results - Moomoo
[144] Bausch Health Companies Inc. SEC Filing - Stock Titan
Bausch + Lomb launches PreserVision AREDS3 eye vitamins in U.S. By Investing.com - Investing.com Australia
Bausch + Lomb launches PreserVision AREDS3 eye vitamins in U.S. - Investing.com UK
Cannabis Pharmaceuticals Business Research Report 2026: An - GlobeNewswire
Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by 2032 from $4.7 Billion in 2025 Featuring AbbVie, Aphria, Aurora Cannabis, Bausch Health, and Canopy Growth - Yahoo Finance
Bausch Health rises on Q1 double beat, 2026 guidance - MSN
Bausch Health Companies (BHC) price target decreased by 10.52% to 6.72 - MSN
Dry Eye Products Market Will Generate Booming Growth - openPR.com
Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference - The Globe and Mail
Hear Bausch Health chiefs in live RBC healthcare chat May 20 - Stock Titan
Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference - 富途牛牛
Bausch Health's Q1 Total Prescriptions Hurt by Exit From Federal Drug Pricing Programs, RBC Says - Moomoo
Bausch Health Cos (BHC) Earnings Date and Reports 2026 $BHC - MarketBeat
Bausch Health to redeem ~$602M of outstanding notes due 2026 - MSN
Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe – Company Announcement - Financial Times
Bausch Health: Strong Margins, Weak Volumes, Equity Story Hinges On Deleveraging - Seeking Alpha
How many employees work at Solta Medical? - Revelio Labs
Bausch Health (BHC) Q1 2026 Earnings Transcript - AOL.com
Bausch Health Companies Inc. (NYSE:BHC) Q1 2026 Earnings Call Transcript - Insider Monkey
MSN Money - MSN
Bausch Health Companies Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:BHC) 2026-05-04 - Seeking Alpha
Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight - GlobeNewswire Inc.
Bausch Health reaffirms 2026 guidance of $5.250B-$5.400B revenue and $2.875B-$2.950B adjusted EBITDA as tariffs are built in - MSN
Bausch Health Companies Q1 2026 Results: Revenue Up 12%, EPS Beats ForecastsNews and Statistics - IndexBox
symbol__ Stock Quote Price and Forecast - CNN
Why Bausch Health Companies was crawling higher this week - MSN
Analysts Have Conflicting Sentiments on These Healthcare Companies: Teladoc (TDOC), Bausch Health Companies (BHC) and AbbVie (ABBV) - The Globe and Mail
Why Bausch Health Companies Was Crawling Higher This Week - The Motley Fool
Bausch Health Companies Inc. Q1 2026 Quarterly Report Highlights Financial Performance, Risks, and Forward-Looking Statements - Minichart
Bausch Health Cos (NYSE:BHC) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Bausch Health Rises on Strong 1Q Segment Growth, Revenue Beat - Moomoo
BHC Q1 Earnings Miss Estimates, Sales Grow on Salix & Solta Strength - The Globe and Mail
RBC Keeps Sector Perform Rating, US$9.00 Price Target, on Bausch Health After Strong Q1 - marketscreener.com
RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $9 - Moomoo
Bausch Health Companies Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Bausch Health Companies Inc. 1Q 2026: Revenue $2.52B, Net income ($1.42B), EPS ($3.82) — 10-Q Summary - TradingView
Bausch Health Cos Q1 Earnings Call Highlights - MarketBeat
Bausch Health (BHC) Lags Q1 Earnings Estimates - Yahoo Finance
Compared to Estimates, Bausch (BHC) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
1.38%
1.89%
자본화:
|
볼륨(24시간):